$1.000
-0.029 (-2.91%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
IVF Prediction & Forecast by Similar Chart Analysis
Alphio's IVF stock price prediction model matches the current INVO Fertility Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.02 (+1.82%). The 1-week path is $1.02 (+1.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy INVO Fertility Inc Stock?
INVO Fertility Inc is a good buy right now due to its recent revenue growth of 17% in Q2 2026, bringing total revenue to $2.18 million, and a significant improvement in shareholder equity from $7.2 million to $16.5 million. The stock is currently priced at $1.00, which is low compared to its historical highs, and the RSI is at 38.076, indicating potential for upward movement. However, the main risk is the year-to-date change of -77.78%, reflecting significant volatility and potential for further declines.
IVF stock price ended at $1.00 on Friday, after losing -2.91%
INVO Fertility Inc (IVF) last closed at $1, losing -2.91%. These facts feed the 1-day and 1-week IVF price prediction above.
Forecast Drivers
INVO Fertility Inc (IVF) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches IVF, ranked by similarity.
Seasonality analysis for IVF
Historically the probability of a positive August return for IVF is 0.00%. February offers the highest probability of a positive month at 32.76%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.